Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Satu Lähelmä"'
Publikováno v:
Pulmonary Therapy, Vol 9, Iss 4, Pp 527-533 (2023)
Abstract Introduction There is increasing pressure to prefer propellant-free inhaler devices over pressurized metered-dose inhalers (pMDI) due to environmental considerations. In this work, we present results from three life cycle assessments (LCAs)
Externí odkaz:
https://doaj.org/article/11859e551f1d4b2dae0e3ebca353ec35
Autor:
Ines Vinge, Jörgen Syk, Athanasios Xanthopoulos, Hendrik Laßmann, Mikko Vahteristo, Ulla Sairanen, Satu Lähelmä, Rudolf Hennig, Matthias Müller
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 15 (2021)
Background: Selection of the most appropriate device for a switch from one inhaler to an equivalent product is known to have a major impact on clinical outcomes in patients with asthma or chronic obstructive pulmonary disease (COPD). Salmeterol/fluti
Externí odkaz:
https://doaj.org/article/4549a50f14a9481c9594b55bf1fed9e0
Autor:
Satu Lähelmä, Ari Lindqvist, Leena Mattila, A Takala, Ville Vartiainen, Rain Jõgi, Mikko Vahteristo
Publikováno v:
International Journal of COPD, Vol Volume 16, Pp 1193-1201 (2021)
International Journal of Chronic Obstructive Pulmonary Disease
International Journal of Chronic Obstructive Pulmonary Disease
Rain Jõgi,1 Leena Mattila,2 Mikko Vahteristo,3 Aino Takala,2 Satu Lähelmä,4 Ville A Vartiainen,2 Ari Lindqvist5 1Tartu University Hospital, Lung Clinic, Tartu, Estonia; 2Medical Affairs, Orion Corporation, Espoo, Finland; 3Research Unit of Pulmona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3d290757d0c265e69a0c7f21f663a60
https://doi.org/10.2147/copd.s298514
https://doi.org/10.2147/copd.s298514
Autor:
Satu Lähelmä, Ville Vartiainen, Mikko Vahteristo, Rain Jõgi, Anna S. Pelkonen, L. Pekka Malmberg
Publikováno v:
Journal of Thoracic Disease. 13:621-631
Background: To evaluate whether patients of varying ages and lung function with asthma or those with chronic obstructive pulmonary disease (COPD) can achieve sufficient inspiratory flows for effective use of the fixed-dose combination of salmeterol-f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::725b93379918855054f5aa83ab42fc0b
https://doi.org/10.21037/jtd-20-2112
https://doi.org/10.21037/jtd-20-2112
Publikováno v:
Journal of Aerosol Medicine and Pulmonary Drug Delivery
Background: Use of drug delivery devices between nebulizers, dry powder inhalers (DPIs), or metered dose inhalers (MDIs), for treating patients with asthma and chronic obstructive pulmonary disease (COPD), is based on patients' capability of coordina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74c935963c7aaa41519828d99e510fe5
http://europepmc.org/articles/PMC7757585
http://europepmc.org/articles/PMC7757585
Autor:
Matthias Müller, Hendrik Laßmann, Satu Lähelmä, Ines Vinge, Jörgen Syk, Rudolf Hennig, Ulla Sairanen, Mikko Vahteristo, Athanasios Xanthopoulos
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 15 (2021)
Background: Selection of the most appropriate device for a switch from one inhaler to an equivalent product is known to have a major impact on clinical outcomes in patients with asthma or chronic obstructive pulmonary disease (COPD). Salmeterol/fluti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a0df27b79b209b9ed7111a1a6dba9a2
https://doaj.org/article/4549a50f14a9481c9594b55bf1fed9e0
https://doaj.org/article/4549a50f14a9481c9594b55bf1fed9e0
Publikováno v:
Journal of Aerosol Medicine and Pulmonary Drug Delivery
Background: The Easyhaler® device-metered dry powder inhaler containing Salmeterol and Fluticasone propionate (S/F) has been developed for the treatment of patients with asthma and chronic obstructive pulmonary disease (COPD). We report two studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba90f741cc74231536067a6f20ad0fbf
https://doi.org/10.1089/jamp.2018.1463
https://doi.org/10.1089/jamp.2018.1463
Autor:
L Pekka, Malmberg, Anna S, Pelkonen, Ville, Vartiainen, Mikko, Vahteristo, Satu, Lähelmä, Rain, Jõgi
Publikováno v:
J Thorac Dis
BACKGROUND: To evaluate whether patients of varying ages and lung function with asthma or those with chronic obstructive pulmonary disease (COPD) can achieve sufficient inspiratory flows for effective use of the fixed-dose combination of salmeterol-f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f1858a61b0bf9cdc3b39d5851b1ea1a5
https://pubmed.ncbi.nlm.nih.gov/33717535
https://pubmed.ncbi.nlm.nih.gov/33717535
Autor:
Mikko Vahteristo, Ville Vartiainen, Satu Lähelmä, Leena Mattila, Ari Lindqvist, Rain Jõgi, A Takala
Publikováno v:
COPD: clinical science.
Background With rising concern on the global warming potential of propellants in pressurized metered dose inhalers (pMDIs) it has become increasingly important to identify patients who are able to safely switch from pMDI to dry powder inhaler (DPI).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5492fe3d9112ac66ef003eecee2d5be1
https://doi.org/10.1136/thorax-2020-btsabstracts.192
https://doi.org/10.1136/thorax-2020-btsabstracts.192
Publikováno v:
Journal of Aerosol Medicine and Pulmonary Drug Delivery
Background: Easyhaler® dry powder inhaler (DPI) containing salmeterol and fluticasone propionate was developed for the treatment of asthma and chronic obstructive pulmonary disease. Three different Salmeterol/fluticasone Easyhaler test products (Ori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49ec057410df406d1ee1c9d78a611b86
https://doi.org/10.1089/jamp.2017.1437
https://doi.org/10.1089/jamp.2017.1437